Stuart Fine
Ophthalmology
Credentials: · · · ·
History
- 1966–1967
Preliminary or Transitional Year
Research
Ranibizumab and bevacizumab for neovascular age-related macular degeneration
New England Journal of Medicine · 2011 · 2,218 citations
Ophthalmology · 2012 · 1,482 citations
Age-related macular degeneration and blindness due to neovascular maculopathy
Archives of Ophthalmology · 1984 · 920 citations
- NB
16 papers
- RM
14 papers
- SB
14 papers
13 papers
12 papers
11 papers · 1 as a fellow
- WG
10 papers
- DG
8 papers
Grants
- 1998–2007
Age-Related Macular Degeneration Prevention Trial
National Eye Institute · U10
Contact PI · $953.9K · University of Pennsylvania
- 1998–2007
Reading Center for Amd Prevention Trial
National Eye Institute · U10
Contact PI · $732K · University of Pennsylvania
- 1985–2005
- 2001–2003
AMD Treatment Network Chairman Clinical Study Planning
National Eye Institute · R21
Contact PI · $50K · University of Pennsylvania
Clinical trials
- 2008–2015
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Study chair · Completed · Phase 3
University of Pennsylvania
- 1999–2006
Complications of Age-Related Macular Degeneration Prevention Trial
Study chair · Completed · Phase 3
National Eye Institute (NEI)